GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (LSE:HIK) » Definitions » FCF Yield %

Hikma Pharmaceuticals (LSE:HIK) FCF Yield % : 9.48 (As of May. 15, 2024)


View and export this data going back to 2005. Start your Free Trial

What is Hikma Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Hikma Pharmaceuticals's Trailing 12-Month Free Cash Flow is £421 Mil, and Market Cap is £4,442 Mil. Therefore, Hikma Pharmaceuticals's FCF Yield % for today is 9.48%.

The historical rank and industry rank for Hikma Pharmaceuticals's FCF Yield % or its related term are showing as below:

LSE:HIK' s FCF Yield % Range Over the Past 10 Years
Min: 1.63   Med: 4.62   Max: 11.03
Current: 9.48


During the past 13 years, the highest FCF Yield % of Hikma Pharmaceuticals was 11.03%. The lowest was 1.63%. And the median was 4.62%.

LSE:HIK's FCF Yield % is ranked better than
90.11% of 1082 companies
in the Drug Manufacturers industry
Industry Median: -0.52 vs LSE:HIK: 9.48

Hikma Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was 28.87%.


Hikma Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Hikma Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals FCF Yield % Chart

Hikma Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.52 3.08 5.99 8.65 10.65

Hikma Pharmaceuticals Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.17 2.28 14.89 4.36 16.70

Competitive Comparison of Hikma Pharmaceuticals's FCF Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Hikma Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hikma Pharmaceuticals's FCF Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hikma Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Hikma Pharmaceuticals's FCF Yield % falls into.



Hikma Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Hikma Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=421.07 / 3955.13909
=10.65%

Hikma Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=330.22 * 2 / 3955.13909
=16.70%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hikma Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Hikma Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Hikma Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hikma Pharmaceuticals (LSE:HIK) Business Description

Traded in Other Exchanges
Address
1 New Burlington Place, London, GBR, W1S 2HR
Hikma Pharmaceuticals PLC is engaged in the development, manufacture, and marketing of a broad range of generic, branded, and in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the company's sales are based in the U.S. and to a lesser degree in the Middle East, North Africa, and Europe.

Hikma Pharmaceuticals (LSE:HIK) Headlines

No Headlines